CUROCELL INC has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Republic of Korea and Australia. Its main competitors in its focus markets biotechnology and pharmaceuticals are PREDDIE RICK E, MG PMC LLC and SHENZHEN IN VIVO BIOMEDICINE TECH LIMITED COMPANY.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Republic of Korea | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Singapore | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Kim Chan Hyuk | 11 |
#2 | Lee Hyeongji | 9 |
#3 | Lee Sang Hoon | 8 |
#4 | Lee Young-Ho | 8 |
#5 | Lee Yujean | 8 |
#6 | Lee Hyeong Ji | 2 |
#7 | Kwon Yong Joon | 2 |
#8 | Lee Yeong Ho | 2 |
#9 | Lee Ji Yeon | 2 |
#10 | Lee Young Ho | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021009701A1 | Enhanced immune cells using dual shrna and composition including the same | |
KR20200108337A | Improved immune cells using binary SHRNA and composition comprising the same | |
WO2018012895A1 | Immune cell surmounting immune checkpoint and pharmaceutical composition containing same immune cell | |
KR20180009040A | Immune cell overcoming immune checkpoint signaling and pharmaceutical composition comprising said immune cell |